Page last updated: 2024-12-11

ym 26734

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

YM 26734: inhibits group II phospholipase A2; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9853400
CHEMBL ID444450
MeSH IDM0223763

Synonyms (30)

Synonym
ym 26734
bdbm50274336
1-{3-dodecanoyl-2,4,6-trihydroxy-5-[7-hydroxy-2-(4-hydroxy-phenyl)-chroman-4-yl]-phenyl}-dodecan-1-one
CHEMBL444450 ,
ym-26734
144337-18-8
d27z1v25bz ,
1-dodecanone, 1,1'-(5-(3,4-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-2h-1-benzopyran-4-yl)-2,4,6-trihydroxy-1,3-phenylene)bis-
4-(3,5-didodecanoyl-2,4,6-trihydroxyphenyl)-7-hydroxy-2-(4-hydroxyphenyl)chroman
unii-d27z1v25bz
AKOS024457146
1,1'-[5-[3,4-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-2h-1-benzopyran-4-yl]-2,4,6-trihydroxy-1,3-phenylene]bis-1-dodecanone
1,1'-(5-(3,4-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-2h-1-benzopyran-4-yl)-2,4,6-trihydroxy-1,3-phenylene)bis(1-dodecanone)
ym-26734, >=95% (hplc)
J-007943
DTXSID20932293
1,1'-{2,4,6-trihydroxy-5-[7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-4-yl]-1,3-phenylene}di(dodecan-1-one)
ym26734
NCGC00387064-05
Q27276004
1-dodecanone, 1,1'-[5-[3,4-dihydro-7-hydroxy-2-(4-hydroxyphenyl)-2h-1-benzopyran-4-yl]-2,4,6-trihydroxy-1,3-phenylene]bis-
1-[3-dodecanoyl-2,4,6-trihydroxy-5-[7-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]phenyl]dodecan-1-one
A899245
1,1'-(2,4,6-trihydroxy-5-(7-hydroxy-2-(4-hydroxyphenyl)chroman-4-yl)-1,3-phenylene)bis(dodecan-1-one) ,
EX-A4737
AS-80369
CS-0029309
HY-108609
AC-36612
F90262
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (8)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Group 10 secretory phospholipase A2Homo sapiens (human)IC50 (µMol)0.90000.04100.10380.2000AID389109; AID389113
Phospholipase A2, membrane associatedOryctolagus cuniculus (rabbit)IC50 (µMol)0.08500.08500.08500.0850AID389111
Phospholipase A2, membrane associatedRattus norvegicus (Norway rat)IC50 (µMol)0.12000.12000.12000.1200AID389106
Phospholipase A2, membrane associatedHomo sapiens (human)IC50 (µMol)0.54000.00301.08118.0000AID389108; AID389112
Phospholipase A2, membrane associatedMus musculus (house mouse)IC50 (µMol)0.03000.03000.08000.1500AID389107
Phospholipase A2 group VHomo sapiens (human)IC50 (µMol)0.11000.10000.22560.5000AID389105
Phospholipase A2 group VMus musculus (house mouse)IC50 (µMol)0.52000.17000.54750.7500AID389104
Group 10 secretory phospholipase A2Mus musculus (house mouse)IC50 (µMol)1.60000.07500.35000.9000AID389110
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (52)

Processvia Protein(s)Taxonomy
axon guidanceGroup 10 secretory phospholipase A2Homo sapiens (human)
lysophospholipid transportGroup 10 secretory phospholipase A2Homo sapiens (human)
prostaglandin biosynthetic processGroup 10 secretory phospholipase A2Homo sapiens (human)
production of molecular mediator involved in inflammatory responseGroup 10 secretory phospholipase A2Homo sapiens (human)
phosphatidylserine metabolic processGroup 10 secretory phospholipase A2Homo sapiens (human)
fertilizationGroup 10 secretory phospholipase A2Homo sapiens (human)
positive regulation of macrophage derived foam cell differentiationGroup 10 secretory phospholipase A2Homo sapiens (human)
positive regulation of lipid storageGroup 10 secretory phospholipase A2Homo sapiens (human)
arachidonic acid metabolic processGroup 10 secretory phospholipase A2Homo sapiens (human)
hair follicle morphogenesisGroup 10 secretory phospholipase A2Homo sapiens (human)
positive regulation of prostaglandin secretionGroup 10 secretory phospholipase A2Homo sapiens (human)
low-density lipoprotein particle remodelingGroup 10 secretory phospholipase A2Homo sapiens (human)
phosphatidylcholine catabolic processGroup 10 secretory phospholipase A2Homo sapiens (human)
intestinal stem cell homeostasisGroup 10 secretory phospholipase A2Homo sapiens (human)
macrophage activationGroup 10 secretory phospholipase A2Homo sapiens (human)
cholesterol homeostasisGroup 10 secretory phospholipase A2Homo sapiens (human)
regulation of macrophage activationGroup 10 secretory phospholipase A2Homo sapiens (human)
erythrocyte maturationGroup 10 secretory phospholipase A2Homo sapiens (human)
negative regulation of DNA-binding transcription factor activityGroup 10 secretory phospholipase A2Homo sapiens (human)
phosphatidylethanolamine metabolic processGroup 10 secretory phospholipase A2Homo sapiens (human)
phosphatidylcholine metabolic processGroup 10 secretory phospholipase A2Homo sapiens (human)
phosphatidylglycerol metabolic processGroup 10 secretory phospholipase A2Homo sapiens (human)
phosphatidic acid metabolic processGroup 10 secretory phospholipase A2Homo sapiens (human)
arachidonic acid secretionGroup 10 secretory phospholipase A2Homo sapiens (human)
negative regulation of inflammatory responseGroup 10 secretory phospholipase A2Homo sapiens (human)
positive regulation of protein metabolic processGroup 10 secretory phospholipase A2Homo sapiens (human)
defense response to virusGroup 10 secretory phospholipase A2Homo sapiens (human)
platelet activating factor catabolic processGroup 10 secretory phospholipase A2Homo sapiens (human)
positive regulation of arachidonic acid secretionGroup 10 secretory phospholipase A2Homo sapiens (human)
negative regulation of cholesterol effluxGroup 10 secretory phospholipase A2Homo sapiens (human)
negative regulation of cytokine production involved in inflammatory responseGroup 10 secretory phospholipase A2Homo sapiens (human)
cellular response to leukemia inhibitory factorGroup 10 secretory phospholipase A2Homo sapiens (human)
positive regulation of acrosome reactionGroup 10 secretory phospholipase A2Homo sapiens (human)
phospholipid metabolic processGroup 10 secretory phospholipase A2Homo sapiens (human)
phospholipid metabolic processPhospholipase A2, membrane associatedHomo sapiens (human)
inflammatory responsePhospholipase A2, membrane associatedHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPhospholipase A2, membrane associatedHomo sapiens (human)
lipid catabolic processPhospholipase A2, membrane associatedHomo sapiens (human)
killing of cells of another organismPhospholipase A2, membrane associatedHomo sapiens (human)
low-density lipoprotein particle remodelingPhospholipase A2, membrane associatedHomo sapiens (human)
intestinal stem cell homeostasisPhospholipase A2, membrane associatedHomo sapiens (human)
phosphatidylethanolamine metabolic processPhospholipase A2, membrane associatedHomo sapiens (human)
phosphatidylcholine metabolic processPhospholipase A2, membrane associatedHomo sapiens (human)
phosphatidic acid metabolic processPhospholipase A2, membrane associatedHomo sapiens (human)
arachidonic acid secretionPhospholipase A2, membrane associatedHomo sapiens (human)
positive regulation of inflammatory responsePhospholipase A2, membrane associatedHomo sapiens (human)
defense response to Gram-positive bacteriumPhospholipase A2, membrane associatedHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadePhospholipase A2, membrane associatedHomo sapiens (human)
regulation of neutrophil activationPhospholipase A2, membrane associatedHomo sapiens (human)
negative regulation of T cell proliferationPhospholipase A2, membrane associatedHomo sapiens (human)
fatty acid metabolic processPhospholipase A2 group VHomo sapiens (human)
positive regulation of phospholipase activityPhospholipase A2 group VHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPhospholipase A2 group VHomo sapiens (human)
leukotriene biosynthetic processPhospholipase A2 group VHomo sapiens (human)
low-density lipoprotein particle remodelingPhospholipase A2 group VHomo sapiens (human)
phosphatidylcholine catabolic processPhospholipase A2 group VHomo sapiens (human)
cardiolipin acyl-chain remodelingPhospholipase A2 group VHomo sapiens (human)
positive regulation of phagocytosisPhospholipase A2 group VHomo sapiens (human)
positive regulation of ERK1 and ERK2 cascadePhospholipase A2 group VHomo sapiens (human)
positive regulation of immune complex clearance by monocytes and macrophagesPhospholipase A2 group VHomo sapiens (human)
phagosome-lysosome fusionPhospholipase A2 group VHomo sapiens (human)
positive regulation of opsonizationPhospholipase A2 group VHomo sapiens (human)
positive regulation of antifungal innate immune responsePhospholipase A2 group VHomo sapiens (human)
positive regulation of phagosome maturationPhospholipase A2 group VHomo sapiens (human)
phospholipid metabolic processPhospholipase A2 group VHomo sapiens (human)
negative regulation of T cell proliferationPhospholipase A2 group VHomo sapiens (human)
arachidonic acid secretionPhospholipase A2 group VHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
1-alkyl-2-acetylglycerophosphocholine esterase activityGroup 10 secretory phospholipase A2Homo sapiens (human)
phospholipase activityGroup 10 secretory phospholipase A2Homo sapiens (human)
phospholipase A2 activityGroup 10 secretory phospholipase A2Homo sapiens (human)
protein bindingGroup 10 secretory phospholipase A2Homo sapiens (human)
calcium-dependent phospholipase A2 activityGroup 10 secretory phospholipase A2Homo sapiens (human)
phospholipid bindingGroup 10 secretory phospholipase A2Homo sapiens (human)
calcium ion bindingGroup 10 secretory phospholipase A2Homo sapiens (human)
phospholipase A2 activityPhospholipase A2, membrane associatedHomo sapiens (human)
phospholipid bindingPhospholipase A2, membrane associatedHomo sapiens (human)
calcium-dependent phospholipase A2 activityPhospholipase A2, membrane associatedHomo sapiens (human)
calcium ion bindingPhospholipase A2, membrane associatedHomo sapiens (human)
calcium-independent phospholipase A2 activityPhospholipase A2 group VHomo sapiens (human)
calcium-dependent phospholipase A2 activityPhospholipase A2 group VHomo sapiens (human)
calcium ion bindingPhospholipase A2 group VHomo sapiens (human)
phospholipid bindingPhospholipase A2 group VHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (15)

Processvia Protein(s)Taxonomy
acrosomal vesicleGroup 10 secretory phospholipase A2Homo sapiens (human)
extracellular regionGroup 10 secretory phospholipase A2Homo sapiens (human)
extracellular spaceGroup 10 secretory phospholipase A2Homo sapiens (human)
lysosomeGroup 10 secretory phospholipase A2Homo sapiens (human)
extracellular regionPhospholipase A2, membrane associatedHomo sapiens (human)
extracellular spacePhospholipase A2, membrane associatedHomo sapiens (human)
mitochondrial outer membranePhospholipase A2, membrane associatedHomo sapiens (human)
endoplasmic reticulumPhospholipase A2, membrane associatedHomo sapiens (human)
endoplasmic reticulum membranePhospholipase A2, membrane associatedHomo sapiens (human)
plasma membranePhospholipase A2, membrane associatedHomo sapiens (human)
secretory granulePhospholipase A2, membrane associatedHomo sapiens (human)
perinuclear region of cytoplasmPhospholipase A2, membrane associatedHomo sapiens (human)
extracellular exosomePhospholipase A2, membrane associatedHomo sapiens (human)
extracellular regionPhospholipase A2 group VHomo sapiens (human)
Golgi apparatusPhospholipase A2 group VHomo sapiens (human)
plasma membranePhospholipase A2 group VHomo sapiens (human)
early phagosomePhospholipase A2 group VHomo sapiens (human)
phagolysosomePhospholipase A2 group VHomo sapiens (human)
recycling endosomePhospholipase A2 group VHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID389109Inhibition of human sPLA2 group 102008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.
AID389107Inhibition of mouse sPLA2 group 2A2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.
AID389105Inhibition of human sPLA2 group 52008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.
AID389113Inhibition of sPLA2 group 102008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.
AID389106Inhibition of rat sPLA2 group 2A2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.
AID389110Inhibition of mouse sPLA2 group 102008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.
AID389112Inhibition of sPLA2 group 2A2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.
AID389108Inhibition of human sPLA2 group 2A2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.
AID389111Inhibition of rabbit sPLA2 group 2A2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.
AID389104Inhibition of mouse sPLA2 group 52008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Simplified YM-26734 inhibitors of secreted phospholipase A2 group IIA.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.58 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (80.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]